ROSE
LIGHTHEART

WHAT DO YOU DO?

I’m an AI futurist for my research in the field of computational metabolomics. I’ve developed novel machine learning applications for drug discovery, and made significant advances on the problem of de novo metabolite identification from MS2 spectra. I’m an AI builder for my individual contributions at Enveda Biosciences. I’ve prototyped and refactored data pipelines, created reports and figures for medicinal chemistry applications, fine-tuned models using Hugging Face, implemented and trained models from scratch, and run experiments for several preprint publications.

WHAT DOES YOUR COMPANY DO?

Enveda Biosciences is utilizing metabolomics and modern machine learning to map the world’s natural products in order to search for new drugs.